Brussels, 24/07/2013 (Agence Europe) - The European Commission has opened an in-depth investigation to verify whether a German scheme, granting companies in financial difficulties exemptions from a 16% rebate (from 1 August 2010 to 31 December 2013) that pharmaceutical companies are obliged to offer to German public sickness insurance funds and private health insurers, is in line with EU state aid rules.
At this stage, the Commission considers that these derogations involve state aid, as...